Company Profile
Longboard Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- LBPH
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for LBPH.
Company overview
Business overview
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck. Its story centered on a targeted CNS asset and clinical differentiation.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ prior to acquisition, Longboard sat in specialty neuroscience biotechnology.
Business Model Characteristics
The business depended on clinical data, CNS differentiation, and the strategic value of its pipeline.
Position Within the Biotechnology Landscape
Longboard was a focused neuroscience catalyst name and now belongs to biotech M&A history.
Future catalysts
- Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work. The company is still very much a one-program story.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Longboard Pharmaceuticals do?
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck. Its story centered on a targeted CNS asset and clinical differentiation.
On which exchange is LBPH stock listed?
Longboard Pharmaceuticals (LBPH) is associated with NASDAQ, United States, Biopharma.
What is Longboard?
Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work.
Which conditions is Longboard Pharmaceuticals targeting with Longboard?
Longboard Pharmaceuticals is associated with neuroscience based on its company overview and current catalyst commentary.
How does Longboard Pharmaceuticals describe recent progress with Longboard?
Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work.
What is Pharmaceuticals?
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck.
What should investors watch for with Pharmaceuticals?
Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work. The company is still very much a one-program story.
What is Lundbeck?
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck.